Home
Search results “Preoperative radiation for rectal cancer”
Challenges in the neoadjuvant radiation of rectal cancer by R. Glynne-Johns
 
03:24
Preoperative chemoradiation (CRT) has been the standard of care for all patients with clinical stage II and III rectal cancer; this is due to benefits such as a low rate of local recurrence, acceptable toxicity, potential sphincter preservation and potential organ preservation. Some heterogeneous data are currently available that must be analyzed carefully to obtain the best results for the patients. This is an excerpt from AISChannel.com. To watch the full video go here: http://aischannel.com/society/challenges-in-the-neoadjuvant-radiation-of-rectal-cancer/
Views: 167 AIS Channel
Role of Imaging in Rectal Cancer by Dr. Anita Nagadi
 
05:52
Colorectal cancer is among the top 5 cancers worldwide. The objective of rectal imaging in rectal cancer is to help doctors distinguish patients who could benefit from preoperative chemo radiation compared to those who benefit from surgery alone. Dr. Anita Nagadi talks about rectal imaging technique, MRI sequence, and role of MRI in prognosis & post-surgery.
Views: 31 Happidoc Social
End of Stage 3 Colorectal Cancer, with Only Radiation Treatment Left after Surgery and Metastasis
 
07:43
Natural Healing Education Center/ 82-2-2677-3004, 82-10-5703-3004/ 832, Surak-ro, Beolgok-myeon, Nonsan-si, Chungcheongnam-do, Republic of Korea http://healthcounsel.co.kr/ https://blog.naver.com/seedjuice
Which neoadjuvant treatment in rectal cancer?
 
16:36
This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by leading professional societies and organizations. With the focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms, the World Congress will educate and update the broad range of experts who participate in the treatment of gastrointestinal cancers, providing a clear overview for treatment. In this presentation, Dr. In this presentation, Dr. David Sebag-Montefiore discusses which neoadjuvant treatments should be used in rectal cancer, and for whom. © 2015 Imedex, LLC.
Views: 588 ImedexCME
Debate: Optimal neoadjuvant strategy in pancreatic cancer - Preoperative chemotherapy + radiation
 
10:52
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Christopher H. Crane argues that preoperative chemotherapy plus radiation is the optimal neoadjuvant strategy for pancreatic cancer. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI © 2017 Imedex, LLC.
Views: 344 ImedexCME
Advantages of Transperineal Approach for Rectal Cancer following Radiotherapy to Prostate Cancer
 
08:18
This video edit shows the performance of a combined laparoscopic and transperineal approach for a patient who developed rectal cancer after receiving radiotherapy for prostate cancer. It is associated with a text under submission for publication in the journal Colorectal Disease. Click Subscribe to this channel for the most up to date content. Authors: Kenji Kawada*, Koya Hida, Yoshiharu Sakai. Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. * Corresponding author: Kenji Kawada, MD, PhD. Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin- Kawara-cho, Sakyo-ku, Kyoto, Japan, 606-8507, Phone: +81-75-366-7595 FAX: +81-75-366-7642 E-mail: kkawada@kuhp.kyoto-u.ac.jp Video associated with Colorectal Disease Journal (published by Wiley and associated with the Association of Coloproctology Great Britain and Ireland (ACPGBI), European Society of Coloproctology (ESCP) and Spanish Society of Coloproctology (SSC).
Dr. Melis on Avoiding Surgery for Patients With Rectal Cancer
 
01:51
Marcovalerio Melis, MD, associate professor, Department of Surgery, NYU Langone Medical Center, discusses a study examining if surgery can be avoided in patients with advanced rectal cancer by using diffusion-weighted magnetic resonance imaging to predict pathologic response.
Views: 287 OncLiveTV
Imaging in rectal cancer: What is mandatory for optimal staging?
 
16:57
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast includes most of the clinical presentations from this premier meeting. Didactic lectures, case studies, debates, and cutting-edge research from expert international faculty comprise the outstanding content of the World Congress. Earn accreditation for this activity at the following location: http://elc.imedex.com/ELC/Activity-Detail.aspx?activityid=6822 © 2013 Imedex, LLC.
Views: 4862 ImedexCME
Non surgical treatment of rectal cancer
 
04:22
Prof Sun Myint speaks with ecancertv at NCRI 2016 about non surgical treatment of rectal cancer, and how he has successfully treated over 1,000 patients using this technique. The patients have been mostly elderly with early and more advanced tumours, who are not suitable for surgery.
Views: 146 ecancer
Chemo-radiotherapy for the treatment of anal cancer (CORMAC)
 
03:06
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com, https://plus.google.com/communities/115462130054650919641?sqinv=VFJWaER0c2NCRl9ERzRjZWhxQmhzY09kVV84cjRn , ,https://plus.google.com/u/0/+AlexandrosGSfakianakis , https://www.youtube.com/channel/UCQH21WX8Qn5YSTKrlJ3OrmQ , https://www.youtube.com/channel/UCTREJHxB6yt4Gaqs4-mLzDA , https://twitter.com/g_orl?lang=el, https://www.instagram.com/alexandrossfakianakis/, Systematic review of outcome measures following chemo-radiotherapy for the treatment of anal cancer (CORMAC). Colorectal Dis. 2018 Mar 22;: Authors: Fish R, Sanders C, Ryan N, Van der Veer S, Renehan AG, Williamson PR Abstract AIM: Six phase III randomised trials have determined the effectiveness of chemoradiotherapy as primary treatment for anal squamous cell carcinoma (ASCC), but outcomes reported in these trials varied widely, hindering evidence synthesis. To improve reporting in all future trials, we aim to develop a core set of outcomes (COS). As the first stage of COS development, we undertook a systematic review to summarise the outcomes reported in studies evaluating chemoradiotherapy for ASCC. METHOD: Systematic literature searches identified studies evaluating radiotherapy or chemoradiotherapy for ASCC. Outcomes and accompanying definitions were extracted verbatim and categorised into domains. RESULTS: From 5170 abstracts, we identified 95 eligible studies, reporting 1192 outcomes and 533 unique terms. We collapsed these terms into 86 standardised outcomes and five domains: survival; disease activity; life impact (including quality-of-life, QoL); delivery of care; and toxicity. The most commonly reported domains were survival and disease activity, reported in 74 (86%) and 54 (62%) studies, respectively. No outcome was reported in every publication. Over half (43/86) of the standardised outcome terms were reported in less than 5 studies, and 21 (25%) were reported in a single study only. There was wide variation in definitions of disease-free, colostomy-free, and progression-free survival (PFS). Anal continence was reported in only 35 (41%) studies. CONCLUSION: Outcomes reported in studies evaluating chemoradiotherapy for ASCC were heterogenous and definitions varied widely. Outcomes likely to be important to patients such as ano-rectal function, toxicity and QoL have been neglected. A COS for future trials will address these issues. This article is protected by copyright. All rights reserved. PMID: 29566456 [PubMed - as supplied by publisher]
Rectal Cancer
 
00:21
Multiple MR images demonstrate a mass arising along the right aspect of the rectum, with a large polyploid component, as well as extension involving the rectal wall from roughly the 9:00 to 12:00 positions. The mass does appear to demonstrate mesorectal involvement. This is a classic example of rectal cancer with mesorectal involvement. 16BMR2
Views: 351 CTisus
Grand Rounds Presentation on Curing Rectal Cancer
 
53:18
Gastrointestinal Oncology Service Chief Leonard Saltz talks about advances in the personalized treatment and cure of rectal cancer in this Grand Rounds presentation.
Which neoadjuvant chemoradiotherapy regimen in rectal cancer?
 
15:59
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast includes most of the clinical presentations from this premier meeting. Didactic lectures, case studies, debates, and cutting-edge research from expert international faculty comprise the outstanding content of the World Congress. Earn accreditation for this activity at the following location: http://elc.imedex.com/ELC/Activity-Detail.aspx?activityid=6822 © 2013 Imedex, LLC.
Views: 764 ImedexCME
Debate 4: Appropriate Pre-op Therapy in Rectal Cancer - Chemo alone
 
15:06
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the management of gastrointestinal malignancies. Join us as nationally-recognized thought leaders take opposing sides on topics of clinical interest, and present updates in standards of care. In this presentation, Dr. Deborah Schrag argues for the use of chemotherapy alone as pre-op treatment for rectal cancer patients. © 2015 Imedex, LLC.
Views: 131 ImedexCME
CEA and CT May Be Useful to Detect Curable Colorectal Cancer Recurrence a New Study Finds
 
03:46
Please like, subscribe, comment and share! SUBSCRIBE: https://www.youtube.com/user/DrJohnKiel FACEBOOK: https://www.facebook.com/medicinelifestyle TWITTER: https://twitter.com/LifestyleMedYou A little background. Colon cancer is the third most common cancer in the world. Meta-analyses have suggested that CEA and CT are the only modes with significant potential to detect curatively treatable metastatic recurrence in patients with colorectal cancer. 5 year survival rates for metastasis have been improving and the likelihood of survival goes up if metastatic disease is treated before it becomes symptomatic. There are published studies outlining different monitoring strategies, but none that have compared CEA and CT to treatable recurrence on this scale. In conclusion, these results show that intensive follow-up by either scheduled CEA or CT increased the likelihood of detecting a recurrence that can be treated with curative intent. Combined CEA and CT was not superior to either individually. Because CEA testing can be done in primary care, it is likely to be more cost-effective than regular CT imaging. However, if there is an advantage to survival with either monitoring strategy, it is likely to be small.
Views: 4083 Lifestyle Medicine
EMCCC 2010: Outcomes of clinical trials into colorectal radiotherapy treatments
 
05:42
Professor Gerard discusses recent clinical trials including the TME and CRO7 trials that have shown the importance of preoperative radiotherapy in reducing relapse rate and the STAR trial that has shown the benefits of combining of chemotherapy and radiotherapy, escalating the radiotherapy dose to 50 Gy and that capecitabine should be used without oxaliplatin when treating T3 and T4 tumours. Prof Jean-Pierre Gerard - Centre Antoine-Lacassagne, Nice
Views: 199 ecancer
Neoadjuvant Chemotherapy vs. Chemo/Radiation for Stage IIIA NSCLC
 
03:00
Dr. Mark Socinski, University of Pittsburgh Medical Center, compares the use of chemotherapy to chemo/radiation in the preoperative setting in stage IIIA lung cancer. http://cancergrace.org/lung/2016/02/08/gcvl_lu_neoadjuvant_chemotherapy_chemoradiation_stage_iiia_nsclc/
Will Radiation Therapy for Colon Cancer Damage My Organs?
 
01:55
While it is a very natural concern for patients to be concerned that radiation therapy for colon cancer might damage their organs during treatment, Dr. Murty explains that it is also important for them to understand all the meticulous planning that takes place prior to the start of radiation therapy. Dr. Murty received his Doctor of Medicine degree from the University of Medicine and Dentistry - New Jersey Medical school. He completed his internship in internal medicine and residency in radiation oncology at Drexel University College of Medicine in Philadelphia where he served as Chief Resident. He has done research and published on the radiotherapeutic treatment of squamous cell carcinomas of the head and neck of unknown origin and total mesorectal excision of rectal cancers. His publications also include a book chapter on the radiation of vascular tumors of the ocular fundus. VIEW THE ARTICLE: http://www.coloncanceranswers.com/will-radiation-therapy-for-colon-cancer-damage-organs/ LAST WEEK'S VIDEO - The Importance of Learning Genetic Make Up of Colorectal Cancer - https://www.youtube.com/watch?v=gE_tBCIKoiI SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING COLON CANCER NEWS http://www.youtube.com/subscription_c... VISIT COLONCANCERANSWERS.com FOR TONS OF INFORMATIVE VIDEOS http://www.coloncanceranswers.com/ SUGGEST THE NEXT TOPIC FOR OUR COLON CANCER EXPERTS! http://www.coloncanceranswers.com/ CONNECT WITH US! Google+ : http://bit.ly/169ii4g Facebook : https://www.facebook.com/ColonCancerA... Twitter : https://twitter.com/ColonCancerQA
IBD Case Presentation: Bridging the art and science of preventive care needs in IBD - Older Patient
 
15:55
In this presentation from the "Is Timing Everything? Making Vaccination-Related Preventive Care Decisions Early in IBD" symposium, Dr. Sunanda V. Kane discusses the case of 60 yr old with longstanding ileocolonic Crohn’s disease. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Activity-Overview.aspx?activityid=7297&specialty=Gastroenterology © 2018 Imedex, LLC.
Views: 66 ImedexCME
Is CT/RT Still Standard Treatment for all Clinically Staged II and III Rectal Cancer?
 
03:05
AIS CHANNEL INFO: This is a trailer video, watch the full version free here: http://aischannel.com/?p=292 VIDEO DESCRIPTION: Preoperative chemoradiation (CT/RT) followed by surgery has been the standard of care in USA/Europe for all patients with clinical stage II and III rectal cancer. New advances to adapt our behavior.
Views: 51 AIS Channel
Overview of Late-Line Therapies for Metastatic Colorectal Cancer
 
11:00
In Part 1 of the 'Optimizing Dosing Strategy for Late-Line Therapies in mCRC' roundtable discussion, Drs. Grothey, Bekaii-Saab, and Van Cutsem provide an overview of current standards of care for patients with relapsed/refractory metastatic colorectal cancer. Earn CME Credit for this activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7287 © 2018 Imedex, LLC.
Views: 92 ImedexCME
Treatment of surgically resectable colorectal peritoneal metastases
 
19:41
This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by leading professional societies and organizations. With the focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms, the World Congress will educate and update the broad range of experts who participate in the treatment of gastrointestinal cancers, providing a clear overview for treatment. In this presentation, Dr. Brendan J. Moran discusses the treatment of surgically-resectable colorectal peritoneal metastases. © 2015 Imedex, LLC.
Views: 291 ImedexCME
Neoadjuvant and Adjuvant Therapy in Metastatic Colorectal Cancer
 
05:07
Panelists John L. Marshall, MD; Tanios Bekaii-Saab, MD; Cathy Eng, MD; Daniel G. Haller, MD; and Tara E. Seery, MD provide insight on the rationale for neoadjuvant and adjuvant therapy in metastatic colorectal cancer.
Views: 43 OncLiveTV
Low anterior resection for rectum cancer. Operated by Dr. Tariq Akhtar Khan
 
00:13
This was done for a cancer of lower rectum 5 cm away from anal verge. For this previously APR with permanent end colostomy was the only option. Now with the use of these staplers we can preserve the anus without compromising the oncological clearance.
Views: 290 Tariq Khan
The Role of Surgery in Locally Advanced Pancreatic Cancer
 
04:06
The panelists, Johanna Bendell, MD, and Caio Rocha Lima, MD, elaborate on the relevant factors in determining resectability and the role of 5-FU in the adjuvant setting of advanced pancreatic cancer.
Views: 81 OncLiveTV
Dr Reber Speaks on Surgical Strategies in Pancreatic Cancer
 
05:37
We reviewed the history and development of the Whipple operation and the "modified" version now most commonly performed, its increasing safety (operative mortality rates have decreased from 20-25% to less than 1%), its side effects, and current approaches to the management of patients with locally extensive cancers that involve major blood vessels. Data included the rationale and role of neoadjuvant therapy (chemotherapy +/- radiation) given for several weeks before the operation and adjuvant therapy (chemotherapy +/- radiation) given after the operation.
Views: 605 HirshbergFoundation
Is tumor location relevant in the treatment decision in metastatic disease?
 
14:59
The ESMO World Congress on Gastrointestinal Cancer is the premier annual event in gastrointestinal cancer. At this year's meeting, experts from around the world convened in Barcelona, Spain from 29 June - 2 July 2016 to present, discuss, and debate the latest advances, treatment strategies, and guidelines for the treatment of gastrointestinal malignancies. In this presentation, Dr. Heinz-Josef Lenz discusses whether tumor location is relevant in the treatment decision in metastatic disease. © 2016 Imedex, LLC.
Views: 288 ImedexCME
SIRFLOX Study in Colorectal Cancer
 
10:54
In this segment, David Liu, MD; Volker Heinemann, MD; and Marwan Fakih, MD, examine the use of radioembolization in individuals with advanced colorectal cancer with liver metastases.
Views: 231 OncLiveTV
PART 3: Clinical Utility of Angiogenesis Inhibitors in Metastatic Colorectal Cancer
 
10:49
Intense research in recent years has yielded substantial advances in our understanding of the biology of colon and rectal tumors resulting in the identification of essential biologic targets with therapeutic potential within the tumor and its microenvironment. The incorporation of efficacious targeted agents into traditional treatment algorithms for colorectal cancer (CRC) has made significant inroads in treating the disease, with some agents improving survival even in patients with advanced/metastatic disease. Targeted agents directed against the vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) have gained prominence in the last decade. The anti-VEGF monoclonal antibody bevacizumab and the anti-EGFR monoclonal antibodies cetuximab and panitumumab are approved by the United States (US) Food and Drug Administration (FDA) as single agents or in combination with chemotherapy in advanced/metastatic CRC. In addition, multiple other novel angiogenesis inhibitors including a soluble VEGF decoy receptor, multikinase inhibitors, and an anti-VEGF receptor-2 (VEGFR-2) monoclonal antibody are in clinical development. In parallel with the enhanced integration of targeted agents into routine management of metastatic CRC (mCRC), the best combination of agents and selection of appropriate therapy most likely to impact clinical practice are being debated. This E-Learning activity highlights the different mechanisms of actions and latest clinical data with the various anti-angiogenic strategies under investigation for patients with mCRC and providing insights on clinical utility that might impact routine practice.
Views: 190 ImedexCME
How is Brachytherapy Used to Treat Colon Cancer?
 
01:50
Brachytherapy, or the treatment of cancer by the insertion of radioactive implants directly into the tissue, is generally only used in very specialized cases in colon cancer. Dr. Murty explains. Dr. Murty received his Doctor of Medicine degree from the University of Medicine and Dentistry - New Jersey Medical school. He completed his internship in internal medicine and residency in radiation oncology at Drexel University College of Medicine in Philadelphia where he served as Chief Resident. He has done research and published on the radiotherapeutic treatment of squamous cell carcinomas of the head and neck of unknown origin and total mesorectal excision of rectal cancers. His publications also include a book chapter on the radiation of vascular tumors of the ocular fundus. VIEW THE ARTICLE: http://www.coloncanceranswers.com/?p=12125 LAST WEEK'S VIDEO - Why are Genetics in Colon Cancer Important? - http://www.youtube.com/watch?v=Ee94e8rbN8I SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING COLON CANCER NEWS http://www.youtube.com/subscription_c... VISIT COLONCANCERANSWERS.com FOR TONS OF INFORMATIVE VIDEOS http://www.coloncanceranswers.com/ SUGGEST THE NEXT TOPIC FOR OUR COLON CANCER EXPERTS! http://www.coloncanceranswers.com/ CONNECT WITH US! Google+ : http://bit.ly/169ii4g Facebook : https://www.facebook.com/ColonCancerA... Twitter : https://twitter.com/ColonCancerQA
Patient profile and treatment outcome of rectal ... - Bioline International - MAFIADOC.COM
 
04:08
https://goo.gl/gBg1hG Key Words: Autonomic nerve preservation (ANP), Rectal cancer, Short course preoperative radiotherapy, Sphincter salvage, Total mesorectal excision (TME).
Views: 1 MAFIADOC
Early- Versus Late-Onset Colorectal Cancer
 
06:37
In the opening segment to “The Biology of Extending Survival in Metastatic Colorectal Cancer,” John L. Marshall, MD; Dirk Arnold, MD, PhD; Fortunato Ciardiello, MD, PhD; Paul R. Helft, MD; and Tanios Bekaii-Saab, MD, provide insight into global trends in the prevalence of early-onset colorectal cancer and the potential impact on screening guidelines.
Views: 869 OncLiveTV
EMCCC 2010: Advances in TME surgery
 
03:44
Professor van de Velde offers an update on the progress of their international trial investigating whether preoperative radiotherapy is necessary when TME surgery is performed by a highly skilled surgeon. The importance of a skilled surgeon is stressed as an incredibly significant factor in the cancer treatment process. Prof Cornelis van de Velde - Leiden University Medical Center, the Netherlands
Views: 83 ecancer
The Impact of HER2 Amplification in Colorectal Cancer
 
02:23
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 98 Targeted Oncology
How Common is Relapse after Surgery for Colon Cancer? - Ovunc Bardakcioglu, MD
 
00:29
The odds of relapse after colon surgery for cancer depends on the staging, says Ovunc Bardakcioglu, MD, a colon and rectal surgeon at Sunrise Hospital. In this video, he explains what treatments follow surgery, based on staging. Visit our website for more information: http://sunrisehospital.com/
Bowel Cancer UK's Colorectal Cancer Study Day 2017 - A patient's perspective
 
32:49
Listen to Deborah James talk about her experience being diagnosed with advanced bowel cancer and the impact it's had on her and her family. This was one of a number of talk throughout the day, aimed at healthcare professionals to understand more about colorectal cancer (bowel cancer) and how to improve a patient's experience. For more information about our the training and education we provide, please visit: https://www.bowelcanceruk.org.uk/for-health-professionals/training/
Views: 280 Bowel Cancer UK
Week8 day 2
 
04:07
Week 8 of Cancer Treatment
Views: 62 Paul Scupham
Robotic Esophagectomy Post Chemo & Radiation
 
09:53
This video from Consultant and Head of Thoracic Surgical Oncology at Rajiv Gandhi Cancer Institute and Research Centre, Dr. L. M. Darlong, shows robotic mobilization of the esophagus for squamous cell carcinoma following preoperative chemo-radiation. (Mckewan Esophagectomy) The procedure is done in the left lateral decubitus position. Three robotic arms are used along with a utility port for bedside assistance. The video of surgery is very crisp from the da Vinci robotic camera and is augmented with titles pointing at key anatomical points throughout. Not narrated, 09:52
The GI oncologist of the future
 
10:32
In this presentation from the ESMO 19th World Congress on Gastrointestinal Cancer, Dr. Axel Grothey discusses the future of GI oncology and the role of the GI oncologist in the future. Earn CME credit for related activities at http://elc.imedex.com © 2017 Imedex, LLC.
Views: 85 ImedexCME
Debate: How to treat borderline, resectable pancreatic cancer? - Chemotherapy alone
 
18:33
There have been tremendous advancements in the multidisciplinary management of GI cancers in the past decade, with a growing number of new and improved targeted agents and efficacious combination regimens yielding substantial clinical benefits in both early and late stages of the diseases. Moreover, breakthroughs in molecular profiling, cancer immunology, early stage detection, and novel diagnostic techniques have led to accelerated strides in GI cancer research and management. As the field of GI malignancies is continuously evolving, community oncologists must strive to keep abreast of the latest developments and resolve new issues in optimizing the management of esophageal, gastric, hepatocellular, pancreatic, and colorectal cancers. To this end, this webcast highlights the clinically significant information presented during the 2016 Great Debates and Updates in GI Malignancies in New York, New York from April 1-2, 2016. In this presentation, Dr. Michael A. Choti argues that chemotherapy alone is the preferred treatment for borderline, resectable pancreatic cancer. Earn accreditation for this activity at the following location: http://elc.imedex.com/ELC/Activity-Search.aspx?search=7205 © 2016 Imedex, LLC.
Views: 1047 ImedexCME
Mesorectal Excision DVD #2 - Part 3: MRI of the Low Rectum
 
32:55
Mesorectal Excision DVD #2 - Part 3: MRI of the Low Rectum (EUR150049)
Liver directed therapy in incurable mCRC – Radio- or chemoembolisation
 
14:41
This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by leading professional societies and organizations. With the focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms, the World Congress will educate and update the broad range of experts who participate in the treatment of gastrointestinal cancers, providing a clear overview for treatment. In this presentation, Dr. Julien Taieb argues in favor of the use of radio- or chemoembolisation for the liver-directed treatment of incurable metastatic colorectal cancer (mCRC). © 2015 Imedex, LLC.
Views: 112 ImedexCME
EMCCC 2010: Total Mesorectal Excision
 
09:54
In response to the debate topic 'Partial mesorectal excision is adequate for rectal cancer', Prof Heald explains the procedure for a mesorectal excision procedure and describes how partial mesorectal excision is only appropriate when a tumour is in the upper third of the rectum. Prof Heald goes on to offer advice on key decisions that must be made by patients contemplating rectal surgery such as whether to opt for preoperative chemotherapy and radiotherapy or whether to have an anterior excision in which anal sphincter is preserved and highlights the risk of the surgery affecting sexual function. Prof Bill Heald OBE - Pelican Cancer Foundation, UK
Views: 1428 ecancer
Can Colon Cancer Come Back?
 
00:45
Colorectal cancer webmd. There are no clear statistics on recurrence jul 1, 2012 in fact, resecting limited liver metastases selected patients with recurrent colorectal cancer can result a 30. However, even if your cancer does recur, it can still be treated with a bowel that comes back after treatment is called recurrent. When cancer comes back after treatment bowel uk. Can colon cancer come back after treatment? Sharecare. Of other organs where the cancer may have come back or spread, such as liver, lungs ovaries Colon recurrence statistics verywell. At ctca, we use advanced tools to accurately diagnose the disease and develop a targeted treatment discusses colon rectal cancers that return after or spread learning you have cancer has come back can be very hard apr 1, 2015 may wonder how likely it is will long cells remain in body treatment, causing. You can, however, control your diet, exercise frequency, and check ups mar 2, 2017 second cancers after colorectal cancer. Reoperative surgery reoperation for recurrent colorectal cancercolorectal cancer, metastatic or fear of the cancer coming back council victoriauniversity iowa hospitals and clinics. When colon or rectal cancer spreads, it most often spreads to the liver. Find out what happens when it returns colon cancer has returned following an initial treatment with surgery, patients recurrent can be broadly divided into two groups i lower my risk of colorectal progressing or coming back? If the does recur at some point, your options will depend on where nov 12, 2013 follow up care for includes regular physical examinations, come back and appropriate plan you. Colon and rectal cancers often return months or years after treatment oct 2, 2016 colorectal cancer can come back. Colorectal cancer survivors can be affected by a number of health problems, but often major concern is facing again. Your oncologist can provide you and your primary care doctor a written oct 29, 2014 cancer may come back some time after its initial treatment there are number of different reasons. Colorectal cancer webmd colon recurrence statistics verywell 797466 url? Q webcache. Colon cancer recurrence? The asco life after diagnosis bowel australia. Colorectal cancer, metastatic or recurrent topic overview webmdrecurrent colon cancer what happens after treatment for colorectal cancer? . If it has taken a long time to diagnose and treat, there is greater chance that might recur. For the early detection of bowel, breast and cervical cancers colorectal cancer can cause a wide range symptoms. This idea can be frightening sep 9, 2016 in many cases, treatment for bowel cancer will successful, but the come back or recur. The cancer can come back in the bowel close to original site (local it is possible for colon return after treatment. Colon cancer recurrence statistics verywell. This is known as recurrent colon cancer. In addition, having colon cancer can increase your risk for other feb 15, 2012 recurrence of still remains a
Views: 104 Call into Question
Adaptive Hybrid Surgery—On-the-Fly Radiosurgery Assessment
 
07:21
Learn more: https://www.brainlab.com/adaptive-hybrid-surgery Elements Adaptive Hybrid Surgery Analysis provides automated, real time feasibility analysis of adjuvant radiosurgery for treatment of benign skull base tumors, such as vestibular schwannoma and meningioma. The software automatically calculates three different radiotherapy (RT) and stereotactic radiosurgery (SRS) treatment plans and intuitively displays the results. Plan assessment for neurosurgeons is facilitated through an intuitive traffic light concept, while additional information, such as dose volume histograms, can be accessed for interpretation by radiation oncologists. Adaptive Hybrid Surgery supports interdisciplinary collaboration in preoperative planning (e.g. in a tumor board environment) and enables the neurosurgeon to continuously evaluate the feasibility of complementary radiosurgery at any time during the surgical resection. Special thanks to: Dr. Andrew T. Parsa, MD, Michael J. Marchese Chair in Neurosurgery at Northwestern University Feinberg School of Medicine; Dr. Orin Bloch, MD, Assistant Professor in Neurological Surgery and Neurology at Northwestern University Feinberg School of Medicine; Dr. Igor J. Barani, MD, Assistant Professor, Department of Radiation Oncology, University of California, San Francisco
Views: 7688 Brainlab
Radioembolization and Chemoembolization in Colorectal Cancer
 
05:30
In this segment, Marwan Fakih, MD, explains two treatment modalities for individuals with advanced liver metastases from colorectal cancer who have failed or cannot tolerate chemotherapy.
Views: 239 OncLiveTV
CEA
 
07:44
CEA
Monitoring colorectal cancer and selected other cancers such as medullary thyroid carcinoma  May be useful in assessing the effectiveness of chemotherapy or radiation treatment  Carcinoembryonic antigen levels are not useful in screening the general population for undetected cancers. News Theme 1 by Audionautix is licensed under a Creative Commons Attribution licence.
Views: 967 Sachin Kale
Debate: Does radiation therapy play a role in gastric cancer adjuvant therapy? - Yes
 
08:19
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Christopher H. Crane argues that post-operative radition therapy is required in this setting. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI © 2017 Imedex, LLC.
Views: 162 ImedexCME